McDonald Capital Investors’s Turning Point Therapeutics, Inc. Common Stock TPTX Stock Holding History

McDonald Capital Investors’s Portfolio TPTX Stock Details TPTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-8,625	Closed	-$649K	–	24
2022 Q2	$649K	Buy	+8,625	New	+$383K	0.05%	20

McDonald Capital Investors's TPTX Position: Q3 2022 in Review

McDonald Capital Investors sold out of Turning Point Therapeutics, Inc. Common Stock (TPTX) in Q3 2022, closing a stake of 8,625 shares — an estimated $649K sold.

McDonald Capital Investors first reported a position in TPTX in Q2 2022 and held it in 1 quarter. The position peaked at $649K in Q2 2022. 0 funds tracked by Wall St. Rank hold TPTX as of Q3 2022.

McDonald Capital Investors reported no remaining Turning Point Therapeutics, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
McDonald Capital Investors sold 8,625 Turning Point Therapeutics, Inc. Common Stock shares in Q3 2022, an estimated $649K.
McDonald Capital Investors first reported a position in Turning Point Therapeutics, Inc. Common Stock in Q2 2022 and held it in 1 quarter.
McDonald Capital Investors's Turning Point Therapeutics, Inc. Common Stock position peaked at $649K in Q2 2022.
0 funds tracked by Wall St. Rank held Turning Point Therapeutics, Inc. Common Stock as of Q3 2022.

Based on McDonald Capital Investors's 13F filing for Q3 2022, filed 4 Nov 2022.